Welcome to LookChem.com Sign In|Join Free

CAS

  • or

869116-13-2

Post Buying Request

869116-13-2 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

869116-13-2 Usage

Description

(S)-2-(((Benzyloxy)carbonyl)amino)pent-4-ynoic acid is a chemical compound derived from the amino acid alanine, characterized by the molecular formula C16H17NO4. (S)-2-(((benzyloxy)carbonyl)aMino)pent-4-ynoic acid features a benzyloxy carbonyl group replacing the hydrogen atom on the alpha carbon and possesses an alkyne functionality. It is known for its potential applications in peptide synthesis, drug development, and enzyme inhibition, particularly targeting dipeptidyl peptidase-4 (DPP-4), which could be beneficial in treating type 2 diabetes.

Uses

Used in Pharmaceutical Industry:
(S)-2-(((Benzyloxy)carbonyl)amino)pent-4-ynoic acid is used as a building block for peptide synthesis, allowing for the creation of novel peptide-based drugs with potential therapeutic applications.
Used in Drug Development:
(S)-2-(((benzyloxy)carbonyl)aMino)pent-4-ynoic acid is utilized as a potential inhibitor of dipeptidyl peptidase-4 (DPP-4) enzymes, which could be instrumental in the development of treatments for type 2 diabetes and other related conditions.
Used in Bioconjugation Applications:
The alkyne functionality present in (S)-2-(((benzyloxy)carbonyl)amino)pent-4-ynoic acid makes it a valuable candidate for conjugation to other molecules, opening up possibilities for various bioconjugation applications in research and therapeutic development.
Overall, (S)-2-(((benzyloxy)carbonyl)amino)pent-4-ynoic acid is a versatile and promising compound with potential applications in the pharmaceutical and biotechnology industries, particularly in the areas of peptide synthesis, drug development, and bioconjugation.

Check Digit Verification of cas no

The CAS Registry Mumber 869116-13-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,6,9,1,1 and 6 respectively; the second part has 2 digits, 1 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 869116-13:
(8*8)+(7*6)+(6*9)+(5*1)+(4*1)+(3*6)+(2*1)+(1*3)=192
192 % 10 = 2
So 869116-13-2 is a valid CAS Registry Number.

869116-13-2Relevant articles and documents

Synthesis of L-[5-11C]Leucine and L-α-[5-11C]Methylleucine via Pd0-mediated 11C-Methylation and Microfluidic Hydrogenation: Potentiality of Leucine PET Probes for Tumor Imaging

Takatani, Shuhei,Tahara, Tsuyoshi,Tsuji, Mieko,Ozaki, Daiki,Shibata, Nina,Hashizume, Yoshinobu,Suzuki, Masaaki,Onoe, Hirotaka,Watanabe, Yasuyoshi,Doi, Hisashi

, p. 3271 - 3279 (2021)

The efficient synthesis of L-[5-11C]leucine and L-α-[5-11C]methylleucine has been investigated using a continuous two-step sequence of rapid reactions consisting of Pd0-mediated 11C-methylation and microfluidic hydrogenation. The synthesis of L-[5-11C]leucine and L-α-[5-11C]methylleucine was accomplished within 40 min with a decay-corrected radiochemical yield of 15–38 % based on [11C]CH3I, radiochemical purity of 95–99 %, and chemical purity of 95–99 %. The Pd impurities in the injectable solution measured using inductively coupled plasma mass spectrometry met the international criteria for human use. Positron emission tomography scanning after an intravenous injection of L-[5-11C]leucine or L-α-[5-11C]methyl leucine in A431 tumor-bearing mice was performed. As a result, L-α-[5-11C]methylleucine was found to be a potentially useful probe for visualizing the tumor. Tissue distribution analysis showed that the accumulation value of L-α-[5-11C]methylleucine in tumor tissue was high [12±3% injected dose/g tissue (%ID/g)].

An improved large scale procedure for the preparation of N-Cbz amino acids

Pehere, Ashok D.,Abell, Andrew D.

experimental part, p. 1493 - 1494 (2011/05/16)

A simple and scalable method for the preparation of N-Cbz protected amino acids is presented which uses a mixture of aqueous sodium carbonate and sodium bicarbonate to maintain the appropriate pH during the addition of benzyl chloroformate. The method has been extended to other N-protections and is amenable to large scale preparation of an intermediate toward Zofenopril, an ACE inhibitor.

Chemoenzymatic synthesis of triazole-linked glycopeptides

Groothuys, Stan,Kuijpers, Brian H. M.,Quaedflieg, Peter J. L. M.,Roelen, Harlof C. P. F.,Wiertz, Roel W.,Blaauw, Richard H.,Van Delft, Floris L.,Rutjes, Floris P. J. T.

, p. 3146 - 3152 (2008/02/09)

Triazole-linked glycopeptides are prepared by C-terminal elongation of glycoamino acids with proteinogenic amino acids following a chemical or enzymatic coupling protocol. Two orthogonal routes for a chemoenzymatic strategy were explored, involving a click-reaction before amide bond formation or in reverse order. It was found that enzymatic peptide coupling under the influence of alcalase proceeds cleanly and in high yields, while the resulting dipeptides can be efficiently clicked to acetylene- or azide-containing sugars. Georg Thieme Verlag Stuttgart.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 869116-13-2